Showing results (301-310 of 408) with videos related to
Sort By:
Pageof 41
Cell|September 21, 2023
Mpox infection protects against re-challenge in rhesus macaquesMalika Aid, Michaela Sciacca, Katherine McMahan, et al.The Journal of Infectious Diseases|November 6, 2012
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.Nature Communications|May 21, 2024
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strainsShixia Wang, Kun-Wei Chan, Danlan Wei, et al.Nature|April 14, 2022
Prolonged viral suppression with anti-HIV-1 antibody therapyChristian Gaebler, Lilian Nogueira, Elina Stoffel, et al.Immunity|May 9, 2025
Computationally designed proteins mimic antibody immune evasion in viral evolutionNoor Youssef, Sarah Gurev, Fadi Ghantous, et al.AIDS Research and Human Retroviruses|January 14, 2011
Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and FAna Revilla, Elena Delgado, Elizabeth C Christian, et al.Science (New York, N.Y.)|July 10, 2010
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1Xueling Wu, Zhi-Yong Yang, Yuxing Li, et al.Cell|June 20, 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MicePia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.The Journal of Experimental Medicine|March 1, 2022
Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controllerValérie Lorin, Ignacio Fernández, Guillemette Masse-Ranson, et al.Nature|October 30, 2012
HIV therapy by a combination of broadly neutralizing antibodies in humanized miceFlorian Klein, Ariel Halper-Stromberg, Joshua A Horwitz, et al.Pageof 41